Building A, Level 1, 26 Talavera Rd
Address: Building A, Level 1, 26 Talavera Rd, Macquarie Park NSW 2113
Ph: (61) 02 8988 8000
Today, we're doing great things for the future.
Merck and Schering-Plough merged in 2009 to create a new company, known as MSD in Australia, Asia and Europe and Merck in the USA and Canada. Today, we are one of the largest pharmaceutical companies in the world. We also are a global leader in consumer products and animal care.
Both MSD and Schering-Plough have a long and rich history of working to improve people's health and well-being. Through the years, our researchers have helped to find new ways to treat and prevent illness - from the discovery of vitamin B1, to the first measles vaccine, to cold remedies and antacids, to the first statins to treat high cholesterol. Our scientists have also helped develop many products to improve animal health, including vaccines and antibiotics.
While we are proud of our past, we are enthusiastic about the future of our combined company and we are excited to help create a healthier, brighter future for people around the world.
Beginnings in Australia
In 1952, Sharp & Dohme became a registered Australian company with two employees at a small site in Rockdale. The company began operations as a distributor but with the international merger of Merck & Co. and Sharp & Dohme, a new company was subsequently registered in Australia in 1953: Merck Sharp & Dohme (Australia) Pty Limited.
We will celebrate 60 years of operation in Australia in 2012.
The company is known as Merck in the United States and Canada. Everywhere else, we are known as MSD. Merck & Co., Inc. is the legal name and is listed on the New York Stock Exchange under the symbol "MRK."
Merck is an innovative, global healthcare leader that is committed to improving health and well-being around the world.
Our product offering categories include heart and respiratory health, infectious diseases, sun care and women's health. We continue to focus our research on conditions that affect millions of people around the world - diseases like Alzheimer's, diabetes and cancer - while expanding our strengths in areas like vaccines and biologics.
We also devote extensive time and energy to increasing access to medicines and vaccines through far-reaching programs that donate and deliver our products to the people who need them.
At Merck, we're applying our global reach, financial strength and scientific excellence to do more of what we're passionate about: improving health and improving lives.
Merck. Be well.
|Employees||Approximately 80,000 worldwide (as of Sept. 30, 2013)|
|Headquarters||Whitehouse Station, New Jersey|
|2012 GAAP Revenue||$47.3 billion|
(By Geographic Region)
|2012 R&D Expense||$7.9 billion (excludes restructuring and merger related expenses)|
Merck is a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and consumer and animal health products.
Visit a list of products marketed in the U.S.
Merck has a robust pipeline, with a wide range of product candidates across each phase of development.
View our pipeline.
Kenneth C. Frazier, chairman of the board, president and chief executive officer
Peter N. Kellogg, executive vice president and chief financial officer
|View the list of Executive Committee members.|